These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 36419876)

  • 21. TROAP regulates prostate cancer progression via the WNT3/survivin signalling pathways.
    Ye J; Chu C; Chen M; Shi Z; Gan S; Qu F; Pan X; Yang Q; Tian Y; Wang L; Yang W; Cui X
    Oncol Rep; 2019 Feb; 41(2):1169-1179. PubMed ID: 30431120
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical significance of TROAP in endometrial cancer and the antiproliferative and proapoptotic effects of TROAP knockdown in endometrial cancer cells: integrated utilization of bioinformatic analysis and in vitro test verification.
    Qiao Y; Chen Z; Li W; Li H; Zhou L
    Naunyn Schmiedebergs Arch Pharmacol; 2024 Dec; 397(12):10049-10059. PubMed ID: 38967825
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pan-cancer analysis of the prognostic and immunological role of GJB2: a potential target for survival and immunotherapy.
    Jia Y; Guo B; Zhang W; Wang F; Zhang Y; Zhang Q; Li E
    Front Oncol; 2023; 13():1110207. PubMed ID: 37427102
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Analysis of the role of CHPF in colorectal cancer tumorigenesis and immunotherapy based on bioinformatics and experiments.
    Song Q; Wang P; Wu J; Lu M; Xia Q; Shi Y; Wang Z; Ma X; Zhao Q
    Discov Oncol; 2024 Sep; 15(1):458. PubMed ID: 39292317
    [TBL] [Abstract][Full Text] [Related]  

  • 25. TROAP Promotes Breast Cancer Proliferation and Metastasis.
    Li K; Zhang R; Wei M; Zhao L; Wang Y; Feng X; Yang Y; Yang S; Zhang L
    Biomed Res Int; 2019; 2019():6140951. PubMed ID: 31198787
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A comprehensively prognostic and immunological analysis of actin-related protein 2/3 complex subunit 5 in pan-cancer and identification in hepatocellular carcinoma.
    Huang S; Sun L; Hou P; Liu K; Wu J
    Front Immunol; 2022; 13():944898. PubMed ID: 36148220
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pan-cancer analysis identifies YTHDF2 as an immunotherapeutic and prognostic biomarker.
    Liu W; Liu C; You J; Chen Z; Qian C; Lin W; Yu L; Ye L; Zhao L; Zhou R
    Front Cell Dev Biol; 2022; 10():954214. PubMed ID: 36120577
    [No Abstract]   [Full Text] [Related]  

  • 28. Identifies KCTD5 as a novel cancer biomarker associated with programmed cell death and chemotherapy drug sensitivity.
    Shi YX; Yan JH; Liu W; Deng J
    BMC Cancer; 2023 May; 23(1):408. PubMed ID: 37149576
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Systematic analysis identifies XRCC4 as a potential immunological and prognostic biomarker associated with pan-cancer.
    Yu Y; Sun Y; Li Z; Li J; Tian D
    BMC Bioinformatics; 2023 Feb; 24(1):44. PubMed ID: 36765282
    [TBL] [Abstract][Full Text] [Related]  

  • 30. RAB6B is a potential prognostic marker and correlated with the remolding of tumor immune microenvironment in hepatocellular carcinoma.
    Peng H; Zhu E; Wang J; Du X; Wang C; Yang M; Zhang Y
    Front Pharmacol; 2022; 13():989655. PubMed ID: 36120364
    [No Abstract]   [Full Text] [Related]  

  • 31. High expression of PDZ-binding kinase is correlated with poor prognosis and immune infiltrates in hepatocellular carcinoma.
    Mu W; Xie Y; Li J; Yan R; Zhang J; Liu Y; Fan Y
    World J Surg Oncol; 2022 Jan; 20(1):22. PubMed ID: 35065633
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comprehensive analyses reveal the carcinogenic and immunological roles of ANLN in human cancers.
    Shi Y; Ma X; Wang M; Lan S; Jian H; Wang Y; Wei Q; Zhong F
    Cancer Cell Int; 2022 May; 22(1):188. PubMed ID: 35568883
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pan-cancer bioinformatics analysis of hepatic leukemia factor and further validation in colorectal cancer.
    Lin Y; Xiong Z; Yang Y; Li W; Huang W; Lin M; Zhang S
    Transl Cancer Res; 2024 Jul; 13(7):3299-3317. PubMed ID: 39145052
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Systematic Pan-Cancer Analysis Identifies TREM2 as an Immunological and Prognostic Biomarker.
    Cheng X; Wang X; Nie K; Cheng L; Zhang Z; Hu Y; Peng W
    Front Immunol; 2021; 12():646523. PubMed ID: 33679809
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Downregulation of Methyltransferase-Like 14 Promotes Ovarian Cancer Cell Proliferation Through Stabilizing TROAP mRNA.
    Li Y; Peng H; Jiang P; Zhang J; Zhao Y; Feng X; Pang C; Ren J; Zhang H; Bai W; Liu W
    Front Oncol; 2022; 12():824258. PubMed ID: 35251990
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comprehensive Pan-Cancer Genomic Analysis Reveals PHF19 as a Carcinogenic Indicator Related to Immune Infiltration and Prognosis of Hepatocellular Carcinoma.
    Zhu ZY; Tang N; Wang MF; Zhou JC; Wang JL; Ren HZ; Shi XL
    Front Immunol; 2021; 12():781087. PubMed ID: 35069553
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pan-Cancer Analysis Revealed
    Liu J; Wang Y; Yin J; Yang Y; Geng R; Zhong Z; Ni S; Liu W; Du M; Yu H; Bai J
    J Oncol; 2022; 2022():3477148. PubMed ID: 35069733
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical and Immunological Significance of ANKRD52 in Pan-Cancer.
    Yin HZ; Zhang MC; Wu H
    Biochem Genet; 2024 Dec; 62(6):4335-4358. PubMed ID: 38296907
    [TBL] [Abstract][Full Text] [Related]  

  • 39. YTHDF1 Is a Potential Pan-Cancer Biomarker for Prognosis and Immunotherapy.
    Hu J; Qiu D; Yu A; Hu J; Deng H; Li H; Yi Z; Chen J; Zu X
    Front Oncol; 2021; 11():607224. PubMed ID: 34026603
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cell death-related biomarker SLC2A1 has a significant role in prognosis prediction and immunotherapy efficacy evaluation in pan-cancer.
    Wang Y; Wang K; Zhang H; Jia X; Li X; Sun S; Sun D
    Front Genet; 2022; 13():1068462. PubMed ID: 36712872
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.